Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal

Magatte Ndiaye, Roger Tine, Babacar Faye, Jean L Ndiaye, Ibrahima Diouf, Aminata C Lo, Khadime Sylla, Yemou Dieng, Rachel Hallett, Michael Alifrangis, Oumar Gaye

1 Citation (Scopus)

Abstract

Senegal has since 2003 used sulphadoxine-pyrimethamine (SP) for Intermittent Preventive Treatment (IPT) of malaria in risk groups. However, the large-scale IPT strategy may result in increasing drug resistance. Our study investigated the possible impact of SP-IPT given to infants and children on the prevalence of SP-resistant haplotypes in the Plasmodium falciparum genes Pfdhfr and Pfdhps, comparing sites with and without IPTi/c. P. falciparum positives samples (n=352) were collected from children under 5years of age during two cross-sectional surveys in 2010 and 2011 in three health districts (two on IPTi/c and one without IPTi/c intervention) located in the southern part of Senegal. The prevalence of SP-resistance-related haplotypes in Pfdhfr and Pfdhps was determined by nested PCR followed by sequence-specific oligonucleotide probe (SSOP)-ELISA. The prevalence of the Pfdhfr double mutant haplotypes (CNRN and CICN) was stable between years at
Original languageEnglish
JournalComptes Rendus Biologies
Volume336
Issue number5-6
Pages (from-to)295-300
Number of pages6
ISSN1631-0691
DOIs
Publication statusPublished - May 2013

Fingerprint

Dive into the research topics of 'Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal'. Together they form a unique fingerprint.

Cite this